Stay updated on Lorlatinib in ROS1+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lorlatinib in ROS1+ NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    A new version entry dated 2025-04-29 was added to the Study Record Versions table. No other page content appears to have changed.
    Difference
    0.1%
    Check dated 2025-11-03T01:10:49.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    The page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.
    Difference
    13%
    Check dated 2025-10-05T09:50:07.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.
    Difference
    0.3%
    Check dated 2025-09-28T03:10:00.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2, removing the old revision tag and deleting the small 'Back to Top' element.
    Difference
    0.8%
    Check dated 2025-09-13T17:16:10.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.8%
    Check dated 2025-09-06T14:43:42.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while several location-related terms have been removed.
    Difference
    10%
    Check dated 2025-08-30T11:24:04.000Z thumbnail image

Stay in the know with updates to Lorlatinib in ROS1+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.